HEADER HYDROLASE/HYDROLASE INHIBITOR 19-APR-16 5JFT TITLE ZEBRA FISH CASPASE-3 CAVEAT 5JFT CASPASE SHOULD BE CONNECTED TO THE CHLOROMETHYL KETONE CAVEAT 2 5JFT RESIDUAL TERMINUS OF THE INHIBITOR THROUGH HEMITHIOACETAL CAVEAT 3 5JFT BOND, BUT THE MODEL DOES NOT REFLECT THE IDEAL CAVEAT 4 5JFT HEMITHIOACETAL GEOMETRY. COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE 3, APOPTOSIS-RELATED CYSTEINE PROTEASE A; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CASPASE-3; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: ACE-ASP-GLU-VAL-ASK; COMPND 8 CHAIN: F, C; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: DANIO RERIO; SOURCE 3 ORGANISM_COMMON: ZEBRAFISH; SOURCE 4 ORGANISM_TAXID: 7955; SOURCE 5 GENE: CASP3A, CASP3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: UNIDENTIFIED 'CNM-GROUP' BACTERIUM HXN600; SOURCE 11 ORGANISM_TAXID: 142878 KEYWDS PHAGE DISPLAY SUBSTRATE LIBRARY, SUBSTRATE RECOGNITION, DANIO RERIO, KEYWDS 2 APOPTOSIS, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.B.TUCKER,S.H.MACKENZIE,J.J.MACIAG,H.DIRSCHERL,P.D.SWARTZ,J.A.YODER, AUTHOR 2 P.T.HAMILTON,A.C.CLARK REVDAT 2 02-NOV-16 5JFT 1 JRNL REVDAT 1 26-OCT-16 5JFT 0 JRNL AUTH M.B.TUCKER,S.H.MACKENZIE,J.J.MACIAG,H.DIRSCHERL ACKERMAN, JRNL AUTH 2 P.SWARTZ,J.A.YODER,P.T.HAMILTON,A.CLAY CLARK JRNL TITL PHAGE DISPLAY AND STRUCTURAL STUDIES REVEAL PLASTICITY IN JRNL TITL 2 SUBSTRATE SPECIFICITY OF CASPASE-3A FROM ZEBRAFISH. JRNL REF PROTEIN SCI. V. 25 2076 2016 JRNL REFN ESSN 1469-896X JRNL PMID 27577093 JRNL DOI 10.1002/PRO.3032 REMARK 2 REMARK 2 RESOLUTION. 2.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.28 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.92 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 27818 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.180 REMARK 3 FREE R VALUE TEST SET COUNT : 1998 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 33.9215 - 5.4928 0.99 1997 153 0.2053 0.2340 REMARK 3 2 5.4928 - 4.3627 1.00 1888 148 0.1432 0.1531 REMARK 3 3 4.3627 - 3.8121 1.00 1894 145 0.1344 0.1863 REMARK 3 4 3.8121 - 3.4639 1.00 1865 145 0.1382 0.2133 REMARK 3 5 3.4639 - 3.2158 1.00 1852 144 0.1676 0.2074 REMARK 3 6 3.2158 - 3.0264 0.99 1843 142 0.1783 0.2253 REMARK 3 7 3.0264 - 2.8749 0.99 1846 144 0.1849 0.2949 REMARK 3 8 2.8749 - 2.7498 0.99 1839 142 0.1906 0.2830 REMARK 3 9 2.7498 - 2.6440 0.99 1818 141 0.2008 0.2981 REMARK 3 10 2.6440 - 2.5528 0.99 1817 140 0.1974 0.2751 REMARK 3 11 2.5528 - 2.4730 0.99 1812 140 0.2036 0.2884 REMARK 3 12 2.4730 - 2.4023 0.98 1802 140 0.2105 0.2723 REMARK 3 13 2.4023 - 2.3391 0.97 1783 137 0.2262 0.3288 REMARK 3 14 2.3391 - 2.2820 0.96 1764 137 0.2669 0.3270 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.440 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3872 REMARK 3 ANGLE : 0.890 5254 REMARK 3 CHIRALITY : 0.054 594 REMARK 3 PLANARITY : 0.005 675 REMARK 3 DIHEDRAL : 16.332 2310 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: AUTHORS STATE THAT THERE IS A REMARK 3 FUNDAMENTAL INCOMPATIBILITY IN THE NAMING OF THE INHIBITOR REMARK 3 STRUCTURE AND THE REFINEMENT PROGRAM CANNOT BE MADE TO ESTABLISH REMARK 3 A BOND THAT EXISTS BETWEEN THE INHIBITOR AND THE PROTEIN AT THE REMARK 3 ACTIVE SITE CYSTEINE. REMARK 4 REMARK 4 5JFT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-APR-16. REMARK 100 THE DEPOSITION ID IS D_1000220509. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : INSERTION DEVICE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27818 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.282 REMARK 200 RESOLUTION RANGE LOW (A) : 33.918 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.76 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WERE OBTAINED AT 18 DEG. C BY REMARK 280 THE HANGING DROP VAPOR DIFFUSION METHOD USING 4 UL DROPS THAT REMARK 280 CONTAINED EQUAL VOLUMES OF PROTEIN AND RESERVOIR SOLUTIONS OVER REMARK 280 A 0.5 ML SOLUTION OF 100 MM SODIUM CITRATE, PH 5.1, 17.5% PEG REMARK 280 6000, 10 MM DTT, AND 3 MM NAN3. CRYSTALS APPEARED WITHIN 14 DAYS REMARK 280 AND WERE BRIEFLY IMMERSED IN CRYOGENIC SOLUTION CONTAINING 10% 2- REMARK 280 METHYLPENTANE-2,4-DIOL AND 90% RESERVOIR SOLUTION., PH 8.5, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.45500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.83550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.93450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 67.83550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.45500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.93450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, F, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE AC-ASP-GLU-VAL-ASP-CMK IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: AC-ASP-GLU-VAL-ASP-CMK REMARK 400 CHAIN: F, C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 179 REMARK 465 THR A 180 REMARK 465 ASP A 181 REMARK 465 HIS A 182 REMARK 465 PRO A 183 REMARK 465 ASP A 184 REMARK 465 ILE A 185 REMARK 465 PRO A 186 REMARK 465 ASP A 187 REMARK 465 GLY A 188 REMARK 465 ARG A 189 REMARK 465 HIS B 36 REMARK 465 ASP B 178 REMARK 465 HIS B 179 REMARK 465 THR B 180 REMARK 465 ASP B 181 REMARK 465 HIS B 182 REMARK 465 PRO B 183 REMARK 465 ASP B 184 REMARK 465 ILE B 185 REMARK 465 PRO B 186 REMARK 465 ASP B 187 REMARK 465 GLY B 188 REMARK 465 SER B 283 REMARK 465 GLU B 284 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 38 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 83 CD CE NZ REMARK 470 GLU A 127 CG CD OE1 OE2 REMARK 470 GLU A 190 CG CD OE1 OE2 REMARK 470 MET A 215 CG SD CE REMARK 470 GLU A 277 CG CD OE1 OE2 REMARK 470 PHE B 38 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 60 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 89 CG CD CE NZ REMARK 470 GLU B 176 CG CD OE1 OE2 REMARK 470 ARG B 189 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 190 CD OE1 OE2 REMARK 470 GLU B 226 CD OE1 OE2 REMARK 470 GLU B 234 CD OE1 OE2 REMARK 470 GLU B 236 CG CD OE1 OE2 REMARK 470 MET B 258 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 454 O HOH A 468 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP C 5 CB - CA - C ANGL. DEV. = -12.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 37 99.03 154.88 REMARK 500 ARG A 67 67.41 -102.56 REMARK 500 ASP A 93 73.19 46.56 REMARK 500 THR A 135 -168.32 -169.13 REMARK 500 ARG A 147 153.56 -46.90 REMARK 500 ALA A 165 149.01 -174.97 REMARK 500 ASP A 197 30.29 71.40 REMARK 500 ARG B 61 7.68 -62.51 REMARK 500 ARG B 67 68.01 -102.12 REMARK 500 SER B 123 -178.86 -174.30 REMARK 500 ARG B 147 151.06 -49.76 REMARK 500 ALA B 165 143.65 -176.99 REMARK 500 CYS B 166 150.82 -49.82 REMARK 500 GLU B 190 108.56 97.96 REMARK 500 ASP B 197 30.84 70.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MRD A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE C 1 and ASP C 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ASP C 5 and 0QE C 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE F 1 and ASP F 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ASP F 5 and 0QE F 6 DBREF 5JFT A 36 282 UNP Q98UI8 Q98UI8_DANRE 36 282 DBREF 5JFT B 36 282 UNP Q98UI8 Q98UI8_DANRE 36 282 DBREF 5JFT F 1 6 PDB 5JFT 5JFT 1 6 DBREF 5JFT C 1 6 PDB 5JFT 5JFT 1 6 SEQADV 5JFT SER A 283 UNP Q98UI8 EXPRESSION TAG SEQADV 5JFT GLU A 284 UNP Q98UI8 EXPRESSION TAG SEQADV 5JFT SER B 283 UNP Q98UI8 EXPRESSION TAG SEQADV 5JFT GLU B 284 UNP Q98UI8 EXPRESSION TAG SEQRES 1 A 249 HIS ALA PHE ARG TYR SER LEU ASN TYR PRO ASN ILE GLY SEQRES 2 A 249 HIS CYS ILE ILE ILE ASN ASN LYS ASN PHE ASP ARG ARG SEQRES 3 A 249 THR GLY MET ASN PRO ARG ASN GLY THR ASP VAL ASP ALA SEQRES 4 A 249 GLY ASN VAL MET ASN VAL PHE ARG LYS LEU GLY TYR ILE SEQRES 5 A 249 VAL LYS VAL TYR ASN ASP GLN THR VAL ALA GLN ILE MET SEQRES 6 A 249 GLN VAL LEU THR THR VAL ALA HIS ASP ASP HIS SER ARG SEQRES 7 A 249 CYS ALA SER LEU VAL CYS VAL LEU LEU SER HIS GLY ASP SEQRES 8 A 249 GLU GLY VAL PHE PHE GLY THR ASP THR SER VAL ASP LEU SEQRES 9 A 249 LYS SER LEU THR SER LEU PHE ARG GLY ASP ARG CYS PRO SEQRES 10 A 249 SER LEU VAL GLY LYS PRO LYS LEU PHE PHE ILE GLN ALA SEQRES 11 A 249 CYS ARG GLY THR GLU LEU ASP PRO GLY VAL GLU THR ASP SEQRES 12 A 249 HIS THR ASP HIS PRO ASP ILE PRO ASP GLY ARG GLU ARG SEQRES 13 A 249 ILE PRO VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR SEQRES 14 A 249 VAL PRO GLY TYR TYR SER TRP ARG ASN THR MET THR GLY SEQRES 15 A 249 SER TRP PHE ILE GLN SER LEU CYS GLU MET MET THR LYS SEQRES 16 A 249 TYR GLY SER GLU LEU GLU LEU LEU GLN ILE MET THR ARG SEQRES 17 A 249 VAL ASN HIS LYS VAL ALA LEU ASP PHE GLU SER THR SER SEQRES 18 A 249 ASN MET PRO GLY PHE ASP ALA LYS LYS GLN ILE PRO CYS SEQRES 19 A 249 ILE VAL SER MET LEU THR LYS GLU MET TYR PHE THR PRO SEQRES 20 A 249 SER GLU SEQRES 1 B 249 HIS ALA PHE ARG TYR SER LEU ASN TYR PRO ASN ILE GLY SEQRES 2 B 249 HIS CYS ILE ILE ILE ASN ASN LYS ASN PHE ASP ARG ARG SEQRES 3 B 249 THR GLY MET ASN PRO ARG ASN GLY THR ASP VAL ASP ALA SEQRES 4 B 249 GLY ASN VAL MET ASN VAL PHE ARG LYS LEU GLY TYR ILE SEQRES 5 B 249 VAL LYS VAL TYR ASN ASP GLN THR VAL ALA GLN ILE MET SEQRES 6 B 249 GLN VAL LEU THR THR VAL ALA HIS ASP ASP HIS SER ARG SEQRES 7 B 249 CYS ALA SER LEU VAL CYS VAL LEU LEU SER HIS GLY ASP SEQRES 8 B 249 GLU GLY VAL PHE PHE GLY THR ASP THR SER VAL ASP LEU SEQRES 9 B 249 LYS SER LEU THR SER LEU PHE ARG GLY ASP ARG CYS PRO SEQRES 10 B 249 SER LEU VAL GLY LYS PRO LYS LEU PHE PHE ILE GLN ALA SEQRES 11 B 249 CYS ARG GLY THR GLU LEU ASP PRO GLY VAL GLU THR ASP SEQRES 12 B 249 HIS THR ASP HIS PRO ASP ILE PRO ASP GLY ARG GLU ARG SEQRES 13 B 249 ILE PRO VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR SEQRES 14 B 249 VAL PRO GLY TYR TYR SER TRP ARG ASN THR MET THR GLY SEQRES 15 B 249 SER TRP PHE ILE GLN SER LEU CYS GLU MET MET THR LYS SEQRES 16 B 249 TYR GLY SER GLU LEU GLU LEU LEU GLN ILE MET THR ARG SEQRES 17 B 249 VAL ASN HIS LYS VAL ALA LEU ASP PHE GLU SER THR SER SEQRES 18 B 249 ASN MET PRO GLY PHE ASP ALA LYS LYS GLN ILE PRO CYS SEQRES 19 B 249 ILE VAL SER MET LEU THR LYS GLU MET TYR PHE THR PRO SEQRES 20 B 249 SER GLU SEQRES 1 F 6 ACE ASP GLU VAL ASP 0QE SEQRES 1 C 6 ACE ASP GLU VAL ASP 0QE HET ACE F 1 3 HET 0QE F 6 1 HET ACE C 1 3 HET 0QE C 6 1 HET MPD A 301 8 HET MRD A 302 8 HETNAM ACE ACETYL GROUP HETNAM 0QE CHLOROMETHANE HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETNAM MRD (4R)-2-METHYLPENTANE-2,4-DIOL HETSYN 0QE CHLORO METHYL GROUP FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 0QE 2(C H3 CL) FORMUL 5 MPD C6 H14 O2 FORMUL 6 MRD C6 H14 O2 FORMUL 7 HOH *130(H2 O) HELIX 1 AA1 ASP A 59 GLY A 63 5 5 HELIX 2 AA2 GLY A 69 LEU A 84 1 16 HELIX 3 AA3 THR A 95 ASP A 109 1 15 HELIX 4 AA4 LEU A 139 SER A 144 1 6 HELIX 5 AA5 LEU A 145 ARG A 147 5 3 HELIX 6 AA6 CYS A 151 VAL A 155 5 5 HELIX 7 AA7 TRP A 219 GLY A 232 1 14 HELIX 8 AA8 GLU A 236 PHE A 252 1 17 HELIX 9 AA9 ASP B 59 GLY B 63 5 5 HELIX 10 AB1 GLY B 69 LEU B 84 1 16 HELIX 11 AB2 THR B 95 ASP B 109 1 15 HELIX 12 AB3 LEU B 139 SER B 144 1 6 HELIX 13 AB4 LEU B 145 ARG B 147 5 3 HELIX 14 AB5 CYS B 151 VAL B 155 5 5 HELIX 15 AB6 TRP B 219 GLY B 232 1 14 HELIX 16 AB7 GLU B 236 PHE B 252 1 17 SHEET 1 AA112 ILE A 87 ASN A 92 0 SHEET 2 AA112 ASN A 46 ASN A 54 1 N ILE A 52 O TYR A 91 SHEET 3 AA112 CYS A 114 LEU A 122 1 O VAL A 120 N ILE A 51 SHEET 4 AA112 LYS A 159 GLN A 164 1 O GLN A 164 N LEU A 121 SHEET 5 AA112 PHE A 198 TYR A 202 1 O ALA A 201 N PHE A 161 SHEET 6 AA112 CYS A 269 SER A 272 -1 O VAL A 271 N TYR A 200 SHEET 7 AA112 CYS B 269 SER B 272 -1 O SER B 272 N ILE A 270 SHEET 8 AA112 PHE B 198 TYR B 202 -1 N TYR B 200 O VAL B 271 SHEET 9 AA112 LYS B 159 GLN B 164 1 N PHE B 161 O ALA B 201 SHEET 10 AA112 CYS B 114 LEU B 122 1 N LEU B 117 O LEU B 160 SHEET 11 AA112 ASN B 46 ASN B 54 1 N ILE B 51 O VAL B 120 SHEET 12 AA112 ILE B 87 ASN B 92 1 O TYR B 91 N ILE B 52 SHEET 1 AA2 3 GLY A 125 ASP A 126 0 SHEET 2 AA2 3 VAL A 129 PHE A 131 -1 O VAL A 129 N ASP A 126 SHEET 3 AA2 3 SER A 136 ASP A 138 -1 O VAL A 137 N PHE A 130 SHEET 1 AA3 2 GLY A 168 GLU A 170 0 SHEET 2 AA3 2 GLY A 207 TYR A 208 1 O GLY A 207 N GLU A 170 SHEET 1 AA4 2 VAL A 175 GLU A 176 0 SHEET 2 AA4 2 ARG B 191 ILE B 192 -1 O ILE B 192 N VAL A 175 SHEET 1 AA5 2 ARG A 191 ILE A 192 0 SHEET 2 AA5 2 VAL B 175 GLU B 176 -1 O VAL B 175 N ILE A 192 SHEET 1 AA6 3 GLY A 217 SER A 218 0 SHEET 2 AA6 3 TRP A 211 ASN A 213 -1 N ASN A 213 O GLY A 217 SHEET 3 AA6 3 GLU F 3 VAL F 4 -1 O GLU F 3 N ARG A 212 SHEET 1 AA7 3 GLY B 125 ASP B 126 0 SHEET 2 AA7 3 VAL B 129 PHE B 131 -1 O VAL B 129 N ASP B 126 SHEET 3 AA7 3 SER B 136 ASP B 138 -1 O VAL B 137 N PHE B 130 SHEET 1 AA8 3 GLY B 217 SER B 218 0 SHEET 2 AA8 3 TRP B 211 ASN B 213 -1 N ASN B 213 O GLY B 217 SHEET 3 AA8 3 GLU C 3 VAL C 4 -1 O GLU C 3 N ARG B 212 LINK C ACE F 1 N ASP F 2 1555 1555 1.34 LINK C ASP F 5 C1 0QE F 6 1555 1555 1.54 LINK C ACE C 1 N ASP C 2 1555 1555 1.34 LINK C ASP C 5 C1 0QE C 6 1555 1555 1.53 SITE 1 AC1 5 MET A 227 LYS A 230 TYR A 231 ARG A 243 SITE 2 AC1 5 HOH A 439 SITE 1 AC2 4 LYS A 140 THR A 143 TYR A 202 VAL B 205 SITE 1 AC3 7 ARG B 212 ASN B 213 THR B 214 GLU B 253 SITE 2 AC3 7 SER B 254 THR B 255 GLU C 3 SITE 1 AC4 10 ARG B 67 SER B 123 HIS B 124 GLY B 125 SITE 2 AC4 10 GLN B 164 ALA B 165 CYS B 166 SER B 210 SITE 3 AC4 10 ARG B 212 VAL C 4 SITE 1 AC5 8 ARG A 212 ASN A 213 THR A 214 SER A 254 SITE 2 AC5 8 THR A 255 GLU F 3 HOH F 101 HOH F 102 SITE 1 AC6 8 ARG A 67 HIS A 124 GLY A 125 GLN A 164 SITE 2 AC6 8 CYS A 166 SER A 210 ARG A 212 VAL F 4 CRYST1 56.910 77.869 135.671 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017572 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012842 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007371 0.00000